Overview of the microRNA Market
The global microRNA market was valued at $1.61 billion in 2023 and is projected to reach $6.11 billion by 2034, growing at a compound annual growth rate (CAGR) of 12.89% from 2024 to 2034. The increasing prevalence of chronic conditions, along with advancements in biotechnology, are key factors driving the market’s growth.
Download a sample of this report @ https://www.towardshealthcare.com/personalized-scope/5211
Market Insights
- Regional Analysis:
- North America led the market in 2023 with a 41.6% share.
- The Asia Pacific region is expected to experience the fastest growth during the forecast period.
- Products & Services:
- The service segment accounted for the largest market share in 2023.
- Application Areas:
- The cancer segment dominated the market in 2023.
- The infectious diseases segment is projected to grow at the fastest rate during the forecast period.
- End-Use Segments:
- Biotechnology and pharmaceutical companies were the largest end-users of microRNA technologies in 2023.
The Role of microRNA in Diagnostics and Therapeutics
MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate gene expression. In the biotechnology and life sciences industries, they are critical for developing diagnostic tools and therapies. miRNAs play a vital role in controlling gene expression involved in numerous illnesses, including cancer and infectious diseases. As biomarkers, microRNAs help identify the diagnostic, prognostic, and predictive values for patient management and are pivotal in the detection of diseases in tissues and bodily fluids.
The Impact of AI on the microRNA Market
Artificial Intelligence (AI) and machine learning are revolutionizing the microRNA market by improving the discovery and development of miRNA-based therapies. Machine learning techniques help identify new miRNA biomarkers and build high-performance classification models for disease detection, such as cancer. For instance, in July 2023, researchers developed a multiclass cancer detection tool using AI and microRNA, enhancing non-invasive diagnostic methods.
Key Players in the microRNA Market
Leading companies in the microRNA market include:
- Thermo Fisher Scientific, Inc.
- DiamiR Biosciences
- New England Biolabs
- NanoString Technologies, Inc.
- Sanofi
- miRecule
- Alnylam
- BioGenex
- Merck KGaA
- LGC Limited
- Takara Bio, Inc.
- Horizon Discovery Group plc.
- QIAGEN
- GeneCopoeia, Inc.
Recent Developments by Major Companies
- DiamiR Biosciences (New Jersey, U.S.): In July 2024, DiamiR Biosciences prepared to launch its microRNA-based CogniMir blood test for Alzheimer’s risk assessment, following clinical trials. The test measures 24 microRNA targets in plasma using PCR technology.
- MiRecule (Gaithersburg, U.S.): In July 2024, MiRecule partnered with Sanofi to develop a therapy for facioscapulohumeral muscular dystrophy (FSHD) and is raising capital for further development.
Growing Number of Clinical Trials in the microRNA Market
Research into miRNAs as therapeutic targets has led to numerous clinical trials worldwide. A search of the Clinical Trials Database in January 2023 revealed 1,213 studies related to microRNA:
- 414 completed studies
- 91 ongoing studies
- 368 studies in recruitment or pre-recruitment phases
These clinical trials aim to explore miRNA’s potential in drug development, diagnosis, and screening across various human disorders.
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/microrna-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5211
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare